BlockBeats News, April 1st, Decentralized protocol Bio Protocol, focusing on early-stage biotech, announced its first major protocol upgrade on Solana and Base — Bio V1. V1 introduces several features aimed at simplifying and optimizing early-stage biotech funding and development, and introducing novel incentive mechanisms, including:
· A community-governed Launchpad for early-stage funding;
· A liquidity and incentive engine supporting immediate post-funding liquidity and rewards tied to scientific milestones;
· BioAgents, AI-driven agents capable of automating research tasks such as R&D data analysis and experimental design.
BIO token holders can determine which biotech projects get launched and their development direction. In return, they are able to access early allocations of successful projects on the network. In the screening process, BIO token holders decide which new BioDAOs can receive funding support in the Bio V1 Launchpad. By contributing BIO, participants receive discounted BioDAO tokens.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。